Institute for International Research

Online Documentation now Available!

Dear Colleague,

The organizers of the annual September Summit on the Medicaid Drug Rebate Program are proud to bring you a timely update on how Medicare Part D is affecting manufacturers. The mission of IIR's Medicare Part D Congress is to provide pharmaceutical, biotech and generic manufacturers with the most up-to-date data and analysis from CMS, OIG, industry and consultants on the net impact of Medicare Part D. Our expert speaking faculty provides information and tools to help make strategic and tactical adjustments for 2007.

• CMS Keynote Address: Cythnia Tudor, Acting Director, Medicare Drug Benefit Group, Centers for Medicare and Medicaid Services
• State Pharmaceutical Assistance Programs (SPAPs) Panel
• PerformRx presents a managed care perspective on managing dual eligible costs
• Amgen provides an update on changing formulary coverage and next generation strategies for manufacturers
• Best Practices panel for negotiating and contracting with PBMs and Managed Care Plans - just in time for 2007 negotiations!

• OIG provides an update on early implementation results
• CMS Keynote Address: Abby Block, Director, Center for Beneficiary Choices at CMS provides HHS perspective
• Sanofi-Aventis provides an overview of the requirements, opportunities, and challenges with Medication Therapy Management Programs (MTMP)

Wednesday, November 1, 2006 • 5:00pm
This workshop is specifically designed for professionals who have most recently become involved in Medicare Part D and need to develop a Part D skill set fast. The focus is on pharmaceutical manufacturers and the basic understanding of all the "players" in the industry. Understanding of the basics is necessary to ensure success under Part D.

This program provides you with the latest analysis of the data generated after January 1, 2006. Hear first hand from CMS, the OIG, and other manufacturers on how they are adjusting their strategies with regards to the Part D drug benefit. This congress also brings you current updates on one of the most pressing issues on the Hill—Medicaid Reform. Space is limited, so register today. We look forward to greeting you in Baltimore in November!

Sincerely,

Valerie Bowling
General Manager,
Pharmaceutical and Biotech Division
The Institute for International Research